BioSpace News Archive

Business

OraSure Technologies Earnings Conference Call Invitation

The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure’s website.

January 17, 2018
·
1 min read
Drug Development

Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients

The Company remains on track to report top-line results from the study in the second quarter of 2018.

January 17, 2018
·
9 min read
Genetic Analysis Release: New Study Shows GA-Map Gut Microbial Composition Test Successfully Identifies IBS Patients That Can Benefit From FODMAP Diet

Genetic Analysis today announced the publication of a new study in the peer-reviewed journal Digestive Disease and Sciences showing the results of using its GA-map Dysbiosis Test for identifying IBS patients who respond to the FODMAP diet and thus receive symptom relief.

January 17, 2018
·
2 min read
Drug Development

Amarin Announces Commencement of VASCEPA Clinical Development in Mainland China

Under the parties’ February 2015 agreement, Eddingpharm is responsible for Vascepa development, regulatory activities, commercialization and associated costs, including managing and funding this pivotal registration study.

January 17, 2018
·
8 min read
MDxHealth: Shareholder Transparency Declaration - Jan. 17, 2018

Capfi Delen Asset Management is a Belgian Management Company of UCITS. For further information, reference is made to the information published on MDxHealth’s website.

January 17, 2018
·
3 min read
Business

Celsee and IncellDx Sign Co-Commercialization Agreement Following Successful Lung Cancer/CTC PD-L1 Feasibility Study

The statistically-significant feasibility study analyzed PD-L1 expression in paired lung tumor biopsy and peripheral blood specimens using two different molecular analysis technologies, the IncellDx OncoTect iO Single Cell Quantitative PD-L1 assay and the Celsee C-Prep Genesis.

January 17, 2018
·
4 min read
Drug Development

First Chronic Hepatitis B Patient Dosed in China in a Phase I Trial of T101 (Transgene’s TG1050 Technology)

announces that the first patient has been dosed in a Phase 1 clinical trial in China, evaluating T101, a therapeutic vaccine based on Transgene’s immunotherapy technology for the treatment of chronic hepatitis B virus (HBV) infection.

January 17, 2018
·
4 min read
Business

Dentsply Sirona Names Cardinal Health Exec as New Leader

Mr. Casey succeeds Mark A. Thierer, who served as Interim Chief Executive Officer since September 28, 2017.

January 17, 2018
·
4 min read
Biotech Beach

Obalon Therapeutics Announces Proposed Public Offering of Common Stock

All of the shares are being offered by Obalon Therapeutics.

January 17, 2018
·
3 min read
Pharm Country

UroGen Pharma Announces Proposed Public Offering of Ordinary Shares

All ordinary shares to be sold in the offering will be offered by the company.

January 17, 2018
·
3 min read